OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000525$5.1357

Nanjing Red Sun Co Ltd

Agricultural ChemicalsVerified

Nanjing Red Sun Co Ltd exhibits a capital structure with a debt-to-equity ratio of 0.71, indicating moderate leverage. The company's liquidity position is weak, with a current ratio of 0.51 and only CNY 590 in cash and equivalents, which is insufficient to cover short-term obligations. The company's price-to-book ratio of 2.71 suggests that the market values the company at a premium to its book value, but this is not supported by positive earnings or strong asset returns. Profitability metrics are severely negative, with a return on equity of -15.33% and a return on assets of -5.96%, both well below the industry median for Agricultural Chemicals. The company reported a net loss of CNY 378.8 million for the period, with operating income also in negative territory at CNY -388.2 million. Gross profit of CNY 331.7 million is insufficient to cover operating expenses, contributing to the overall unprofitability. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the Chinese agricultural sector. Growth prospects are constrained, with the company reporting a net loss and negative operating income. The outlook for the current fiscal year is not explicitly provided, but the negative earnings trend suggests a challenging operating environment. The company's free cash flow is negative at CNY -213.6 million, and capital expenditures of CNY -136.3 million indicate ongoing investment in operations, though this is not generating positive returns. The company faces significant financial risk, with a liquidity risk score of medium and a key flag indicating that net cash is negative after subtracting total debt. The risk of dilution is currently low, but the company's negative free cash flow and high leverage could necessitate future equity or debt financing, which may dilute existing shareholders. Recent financial filings show a last actual EPS of -0.59 CNY and a last actual revenue of CNY 4.61 billion, both indicating a continued decline in performance. No recent earnings call transcripts or other disclosures are available to provide further insight into management's strategy or operational changes.

30-day price · 000525(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyNanjing Red Sun Co Ltd
Ticker000525.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Nanjing Red Sun Co Ltd is a Chinese chemical company primarily engaged in the production and sale of agricultural chemicals, including fertilizers and pesticides.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

Nanjing Red Sun Co Ltd exhibits a capital structure with a debt-to-equity ratio of 0.71, indicating moderate leverage. The company's liquidity position is weak, with a current ratio of 0.51 and only CNY 590 in cash and equivalents, which is insufficient to cover short-term obligations. The company's price-to-book ratio of 2.71 suggests that the market values the company at a premium to its book value, but this is not supported by positive earnings or strong asset returns. Profitability metrics are severely negative, with a return on equity of -15.33% and a return on assets of -5.96%, both well below the industry median for Agricultural Chemicals. The company reported a net loss of CNY 378.8 million for the period, with operating income also in negative territory at CNY -388.2 million. Gross profit of CNY 331.7 million is insufficient to cover operating expenses, contributing to the overall unprofitability. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the Chinese agricultural sector. Growth prospects are constrained, with the company reporting a net loss and negative operating income. The outlook for the current fiscal year is not explicitly provided, but the negative earnings trend suggests a challenging operating environment. The company's free cash flow is negative at CNY -213.6 million, and capital expenditures of CNY -136.3 million indicate ongoing investment in operations, though this is not generating positive returns. The company faces significant financial risk, with a liquidity risk score of medium and a key flag indicating that net cash is negative after subtracting total debt. The risk of dilution is currently low, but the company's negative free cash flow and high leverage could necessitate future equity or debt financing, which may dilute existing shareholders. Recent financial filings show a last actual EPS of -0.59 CNY and a last actual revenue of CNY 4.61 billion, both indicating a continued decline in performance. No recent earnings call transcripts or other disclosures are available to provide further insight into management's strategy or operational changes.
Key takeaways
  • Nanjing Red Sun Co Ltd is unprofitable, with a return on equity of -15.33% and a net loss of CNY 378.8 million.
  • The company's liquidity position is weak, with a current ratio of 0.51 and minimal cash reserves.
  • Revenue is concentrated in a single business segment, increasing exposure to regional and sector-specific risks.
  • The company's capital expenditures are not generating positive returns, and free cash flow is negative.
  • The risk of dilution is currently low, but the company's financial position may require future financing.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.08B
Gross profit$331.7M
Operating income-$388.2M
Net income-$378.8M
R&D
SG&A
D&A
SBC
Operating cash flow$177.1M
CapEx-$136.3M
Free cash flow-$213.6M
Total assets$6.36B
Total liabilities$3.89B
Total equity$2.47B
Cash & equivalents$590.00
Long-term debt$1.75B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.08B-$388.2M-$378.8M-$213.6M
FY-1$3.01B$1.64B$388.1M$665.4M
FY-2$3.23B-$637.6M-$389.1M-$57.2M
FY-3$6.44B$867.9M$732.3M$615.2M
FY-4$4.68B-$2.14B-$3.74B-$3.65B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$6.36B$2.47B$590.00
FY-1$7.26B$2.86B
FY-2$9.86B$878.8M
FY-3$10.28B$1.27B
FY-4$9.71B$553.9M
PeriodOCFCapExFCFSBC
FY0$177.1M-$136.3M-$213.6M
FY-1$347.0M-$71.0M$665.4M
FY-2$532.9M-$49.6M-$57.2M
FY-3$1.14B-$440.0M$615.2M
FY-4$348.6M-$190.3M-$3.65B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$673.3M$10.2M$3.2M
FQ-1$752.1M-$53.2M-$107.3M
FQ-2$867.2M-$89.7M-$63.1M
FQ-3$612.7M-$273.1M-$237.7M
FQ-4$847.7M$28.8M$29.3M
FQ-5$304.5M$1.62B$361.3M
FQ-6$1.06B$2.8M$5.5M
FQ-7$796.7M-$3.4M$1.2M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$6.54B$2.48B$163.5M
FQ-1$6.36B$2.47B$590.00
FQ-2$6.84B$2.61B$118.6M
FQ-3$7.14B$2.67B$2.5M
FQ-4$7.12B$2.89B$118.4M
FQ-5$7.26B$2.86B
FQ-6$9.83B$915.5M$252.6M
FQ-7$9.77B$903.8M
PeriodOCFCapExFCFSBC
FQ0$100.4M-$72.6M
FQ-1$177.1M-$136.3M
FQ-2$187.4M-$157.6M
FQ-3$131.8M-$112.1M
FQ-4$48.2M-$24.5M
FQ-5$347.0M-$71.0M
FQ-6$255.0M-$92.8M
FQ-7$116.8M-$77.9M
Valuation
Market price$5.13
Market cap$6.69B
Enterprise value$8.43B
P/E
Reported non-GAAP P/E
EV/Revenue2.7
EV/Op income
EV/OCF47.6
P/B2.7
P/Tangible book2.7
Tangible book$2.47B
Net cash-$1.75B
Current ratio0.5
Debt/Equity0.7
ROA-6.0%
ROE-15.3%
Cash conversion-47.0%
CapEx/Revenue-4.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000525Activity
Op margin-12.6%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-12.3%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin10.8%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity71.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Last actual EPS-0.59 CNY
Last actual revenue4,614,454,470 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:41 UTCJob: e77aca06